B-Cell Malignancies: SRG-1505 Treatment Study

We are testing a new treatment called SRG-1505 for individuals with mature B-cell malignancies. This study aims to evaluate its safety and appropriate dosage.

>2 yearsSafety phase (I)HematologyOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Assistance Publique Hopitaux De Paris
Lymphoid malignacies department
Créteil, France
Institut Gustave Roussy
Département d'Innovations Thérapeutiques et d'essais Précoces (DITEP)
Villejuif, France
Azienda Ospedaliera Nazionale Ss Antonio E Biagio E C Arrigo Alessandria
SCDU di Ematologia
Alessandria, Italy

Sponsor: Schrodinger Inc.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.